COVID-19 Antiviral Veklury Approved for Use in Patients With

The FDA has approved the sNDA for Veklury to include COVID-19 treatment in patients with mild to severe hepatic impairment with no dose adjustments.

Related Keywords

, Drug Administration , New Drug Application , Child Pugh Class ,